AVT shall become the pre-eminent developer of advanced cancer and infectious diseases therapies. We shall create rapid revenue and strong earnings by leveraging the production & marketing of Big Pharma.
Provax, the first vaccine which prevents recurrences of Prostate Cancer, serves an even larger patient community. Provax is an easily manufactured, synthetic peptide vaccine that does not require refrigeration, as most vaccines do.
Infectious Disease Vaccines
Leadership is composed of recognized medical and business leaders - with Sloan Kettering heritage, New York Medical College appointments, Cornell University and NY Presbyterian posts - created the intellectual property behind Capridine and Provax
• They are backstopped by an advisory dream team of prominent Oncologists, Geneticists, Cellular Biologists and Immunologists
• From the Cancer Institute of NJ, BU, Baylor , Merck and Antigenics.
A new team of public company professionals and advisors guides AVT from its development stage through profitable operations and value growth.
Jim Hock, Hanover International
Gerald Adler, Newman & Morrison LLP
Seth Farbman, VStock Transfer
Rosenberg & Chesnov
New World Technology Partners